Results from pioneer: A randomized, double-blind, placebo-controlled, phase 2 study of avapritinib in patients with indolent systemic mastocytosis

Authors
Category Primary study
ConferenceHemaSphere
Year 2020
This article has no abstract
Epistemonikos ID: 6d279a50e097dac3853a6c6b333b9b428d01f19d
First added on: Apr 30, 2026